AACG completed a near-total disposition of its operating business in early July 2026, selling the entities that previously held its portfolio training, research-based learning, and overseas study counselling operations for nominal cash consideration of one renminbi, and then closed a private placement on July 21, 2026 that issued 45,306,732 restricted common shares at $0.46667 per share for $21.1 million of gross proceeds. The 8-K-equivalent Form 6-K filed July 2, 2026 discloses pro forma consolidated financials in which, after eliminating the disposed subsidiaries' revenue, cost, and operating expense lines, the surviving parent shows zero net revenues and a $4.9 million shareholders' equity, which means the listed entity on Nasdaq is no longer the same business the FY2025 Form 20-F describes.
The investment question for the next two quarters is no longer how many students ACG enrolled (4,127 in FY2025 versus the post-COVID rebound peak of FY2023) but rather what the $21 million of new capital plus the residual $12.2 million of pre-Disposition cash gets deployed into, and at what valuation the $131.5 million market capitalization is implicitly pricing that deployment. Trading at $0.96 per share against 136.9 million shares outstanding post-Placement, the equity carries an enterprise value near $111 million even though the pro forma book value of continuing operations is approximately $4.9 million, which is the gap the market is paying to back management's next move.
The falsifiable clock is the next Form 6-K disclosing the use of proceeds, an acquisition agreement, or a new business plan, which the Form 6-K narrative of the May 6, 2026 subscription agreement and the June 5, 2026 EGM resolutions imply is the next chapter rather than a return to the disposed operating subsidiaries.